Table 5 Crude and adjusted means of cIMT at baseline and at 1 year follow up
Total Sample | cIMT baseline | cIMT 1 year follow up | P |
|---|---|---|---|
Crude model | 0.770 (0.728–0.812) | 0.874 (0.815–0.932) | <0.001 |
Model adjusted for age | 0.770 (0.738–0.802) | 0.874 (0.816–0.932) | <0.001 |
Model adjusted for age and glucose | 0.770 (0.737–0.803) | 0.874 (0.816–0.932) | <0.001 |
Model adjusted for age, glucose and Triglycerides | 0.770 (0.737–0.803) | 0.874 (0.815–0.933) | 0.001 |
Model adjusted for age, glucose, triglycerides and Systolic Pressure | 0.770 (0.738–0.802) | 0.874 (0.815–0.932) | 0.050 |
Model adjusted for age, glucose, triglycerides, Systolic Pressure and WHR | 0.770 (0.737–0.803) | 0.874 (0.815–0.933) | 0.514 |
Patients with Lipodystrophy | |||
Crude model | 0.817 (0.744–0.889) | 0.919 (0.825–1.01) | 0.030 |
Model adjusted for age | 0.817 (0.757–0.876) | 0.919 (0.826–1.01) | 0.027 |
Model adjusted for age and glucose | 0.817 (0.756–0.877) | 0.919 (0.825–1.01) | 0.018 |
Model adjusted for age, glucose and triglycerides | 0.817 (0.756–0.877) | 0.919 (0.825–1.01) | 0.053 |
Model adjusted for age, glucose, triglycerides and Systolic Pressure | 0.817 (0.756–0.878) | 0.919 (0.825–1.01) | 0.401 |
Model adjusted for age, glucose, triglycerides, Systolic Pressure and WHR | 0.817 (0.755–0.878) | 0.919 (0.823–1.01) | 0.644 |
Patients Without Lipodystrophy | |||
Crude model | 0.733 (0.684–0.784) | 0.838 (0.763–0.914) | 0.020 |
Model adjusted for age | 0.733 (0.698–0.767) | 0.838 (0.763–0.914) | 0.003 |
Model adjusted for age and glucose | 0.733 (0.698–0.768) | 0.838 (0.763–0.914) | 0.015 |
Model adjusted for age, glucose and triglycerides | 0.733 (0.698–0.768) | 0.838 (0.762–0.915) | 0.017 |
Model adjusted for age, glucose, triglycerides and Systolic Pressure | 0.733 (0.698–0.768) | 0.838 (0.762–0.915) | 0.130 |
Model adjusted for age, glucose, triglycerides, Systolic Pressure and WHR | 0.733 (0.698–0.768) | 0.838 (0.761–0.915) | 0.676 |